Literature DB >> 20025935

Molecular mechanisms of pituitary organogenesis: In search of novel regulatory genes.

S W Davis1, F Castinetti, L R Carvalho, B S Ellsworth, M A Potok, R H Lyons, M L Brinkmeier, L T Raetzman, P Carninci, A H Mortensen, Y Hayashizaki, I J P Arnhold, B B Mendonça, T Brue, S A Camper.   

Abstract

Defects in pituitary gland organogenesis are sometimes associated with congenital anomalies that affect head development. Lesions in transcription factors and signaling pathways explain some of these developmental syndromes. Basic research studies, including the characterization of genetically engineered mice, provide a mechanistic framework for understanding how mutations create the clinical characteristics observed in patients. Defects in BMP, WNT, Notch, and FGF signaling pathways affect induction and growth of the pituitary primordium and other organ systems partly by altering the balance between signaling pathways. The PITX and LHX transcription factor families influence pituitary and head development and are clinically relevant. A few later-acting transcription factors have pituitary-specific effects, including PROP1, POU1F1 (PIT1), and TPIT (TBX19), while others, such as NeuroD1 and NR5A1 (SF1), are syndromic, influencing development of other endocrine organs. We conducted a survey of genes transcribed in developing mouse pituitary to find candidates for cases of pituitary hormone deficiency of unknown etiology. We identified numerous transcription factors that are members of gene families with roles in syndromic or non-syndromic pituitary hormone deficiency. This collection is a rich source for future basic and clinical studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20025935      PMCID: PMC2909473          DOI: 10.1016/j.mce.2009.12.012

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  214 in total

1.  Persistent Prop1 expression delays gonadotrope differentiation and enhances pituitary tumor susceptibility.

Authors:  L J Cushman; D E Watkins-Chow; M L Brinkmeier; L T Raetzman; A L Radak; R V Lloyd; S A Camper
Journal:  Hum Mol Genet       Date:  2001-05-15       Impact factor: 6.150

2.  Mutations in the human forkhead transcription factor FOXE3 associated with anterior segment ocular dysgenesis and cataracts.

Authors:  E V Semina; I Brownell; H A Mintz-Hittner; J C Murray; M Jamrich
Journal:  Hum Mol Genet       Date:  2001-02-01       Impact factor: 6.150

3.  Genetic screening of combined pituitary hormone deficiency: experience in 195 patients.

Authors:  Rachel Reynaud; Magali Gueydan; Alexandru Saveanu; Sophie Vallette-Kasic; Alain Enjalbert; Thierry Brue; Anne Barlier
Journal:  J Clin Endocrinol Metab       Date:  2006-05-30       Impact factor: 5.958

4.  Hypomorphic phenotype in mice with pituitary-specific knockout of steroidogenic factor 1.

Authors:  L Zhao; M Bakke; Y Krimkevich; L J Cushman; A F Parlow; S A Camper; K L Parker
Journal:  Genesis       Date:  2001-06       Impact factor: 2.487

5.  Truncating mutations in FOXC2 cause multiple lymphedema syndromes.

Authors:  D N Finegold; M A Kimak; E C Lawrence; K L Levinson; E M Cherniske; B R Pober; J W Dunlap; R E Ferrell
Journal:  Hum Mol Genet       Date:  2001-05-15       Impact factor: 6.150

6.  Reduced expression of the LIM-homeobox gene Lhx3 impairs growth and differentiation of Rathke's pouch and increases cell apoptosis during mouse pituitary development.

Authors:  Yangu Zhao; Donna Chelle Morales; Edit Hermesz; Woon-Kyu Lee; Samuel L Pfaff; Heiner Westphal
Journal:  Mech Dev       Date:  2006-06-14       Impact factor: 1.882

7.  The pan-pituitary activator of transcription, Ptx1 (pituitary homeobox 1), acts in synergy with SF-1 and Pit1 and is an upstream regulator of the Lim-homeodomain gene Lim3/Lhx3.

Authors:  J J Tremblay; C Lanctôt; J Drouin
Journal:  Mol Endocrinol       Date:  1998-03

8.  Sustained Notch signaling in progenitors is required for sequential emergence of distinct cell lineages during organogenesis.

Authors:  Xiaoyan Zhu; Jie Zhang; Jessica Tollkuhn; Ryosuke Ohsawa; Emery H Bresnick; François Guillemot; Ryoichiro Kageyama; Michael G Rosenfeld
Journal:  Genes Dev       Date:  2006-10-01       Impact factor: 11.361

9.  Transient dwarfism and hypogonadism in mice lacking Otx1 reveal prepubescent stage-specific control of pituitary levels of GH, FSH and LH.

Authors:  D Acampora; S Mazan; F Tuorto; V Avantaggiato; J J Tremblay; D Lazzaro; A di Carlo; A Mariano; P E Macchia; G Corte; V Macchia; J Drouin; P Brûlet; A Simeone
Journal:  Development       Date:  1998-04       Impact factor: 6.868

10.  Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans.

Authors:  Daniel Kelberman; Karine Rizzoti; Ariel Avilion; Maria Bitner-Glindzicz; Stefano Cianfarani; Julie Collins; W Kling Chong; Jeremy M W Kirk; John C Achermann; Richard Ross; Danielle Carmignac; Robin Lovell-Badge; Iain C A F Robinson; Mehul T Dattani
Journal:  J Clin Invest       Date:  2006-08-24       Impact factor: 14.808

View more
  55 in total

1.  A recessive mutation resulting in a disabling amino acid substitution (T194R) in the LHX3 homeodomain causes combined pituitary hormone deficiency.

Authors:  Susanne Bechtold-Dalla Pozza; Stefan Hiedl; Julia Roeb; Peter Lohse; Raleigh E Malik; Soyoung Park; Mario Durán-Prado; Simon J Rhodes
Journal:  Horm Res Paediatr       Date:  2012-01-26       Impact factor: 2.852

2.  Lhx4 deficiency: increased cyclin-dependent kinase inhibitor expression and pituitary hypoplasia.

Authors:  Peter Gergics; Michelle L Brinkmeier; Sally A Camper
Journal:  Mol Endocrinol       Date:  2015-02-10

3.  Targeted pituitary overexpression of pituitary adenylate-cyclase activating polypeptide alters postnatal sexual maturation in male mice.

Authors:  Joseph P Moore; Rong Q Yang; Stephen J Winters
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

Review 4.  Pituitary stem cell update and potential implications for treating hypopituitarism.

Authors:  Frederic Castinetti; Shannon W Davis; Thierry Brue; Sally A Camper
Journal:  Endocr Rev       Date:  2011-04-14       Impact factor: 19.871

Review 5.  Pituitary gland development and disease: from stem cell to hormone production.

Authors:  Shannon W Davis; Buffy S Ellsworth; María Inés Peréz Millan; Peter Gergics; Vanessa Schade; Nastaran Foyouzi; Michelle L Brinkmeier; Amanda H Mortensen; Sally A Camper
Journal:  Curr Top Dev Biol       Date:  2013       Impact factor: 4.897

Review 6.  The role of homeodomain transcription factors in heritable pituitary disease.

Authors:  Kelly L Prince; Emily C Walvoord; Simon J Rhodes
Journal:  Nat Rev Endocrinol       Date:  2011-07-26       Impact factor: 43.330

7.  Gonadotrope-specific deletion of Dicer results in severely suppressed gonadotropins and fertility defects.

Authors:  Huizhen Wang; Ian Graham; Richard Hastings; Sumedha Gunewardena; Michelle L Brinkmeier; P Michael Conn; Sally A Camper; T Rajendra Kumar
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

8.  The Homeodomain Transcription Factors Vax1 and Six6 Are Required for SCN Development and Function.

Authors:  Erica C Pandolfi; Joseph A Breuer; Viet Anh Nguyen Huu; Tulasi Talluri; Duong Nguyen; Jessica Sora Lee; Rachael Hu; Kapil Bharti; Dorota Skowronska-Krawczyk; Michael R Gorman; Pamela L Mellon; Hanne M Hoffmann
Journal:  Mol Neurobiol       Date:  2019-11-09       Impact factor: 5.590

9.  Genome-wide analyses of the Jeju, Thoroughbred, and Jeju crossbred horse populations using the high density SNP array.

Authors:  Nam Young Kim; Ha-Seung Seong; Dae Cheol Kim; Nam Geon Park; Byoung Chul Yang; Jun Kyu Son; Sang Min Shin; Jae Hoon Woo; Moon Cheol Shin; Ji Hyun Yoo; Jung-Woo Choi
Journal:  Genes Genomics       Date:  2018-08-11       Impact factor: 1.839

10.  Cold-shock-domain protein A (CSDA) contributes posttranscriptionally to gonadotropin-releasing hormone-regulated expression of Egr1 and indirectly to Lhb.

Authors:  Theodore R Chauvin; Maria K Herndon; John H Nilson
Journal:  Biol Reprod       Date:  2012-02-29       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.